{"data_date":"2026-11-09","library_size":29780,"matched_against":"each record's title and abstract (summary field), case-insensitive","n":114,"page":"https://alzhub.org/answers/metformin-and-dementia","query":"title or abstract mentions \"metformin\"","studies":[{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/glucagon-like-peptide-1-receptor-agonists-and-incidence-of-dementia-40690769","doi":"10.7326/ANNALS-24-02648","journal":"Annals of Internal Medicine","n_participants":7254,"pmid":"40690769","source_url":"https://pubmed.ncbi.nlm.nih.gov/40690769/","study_design":"cohort","title":"Glucagon-Like Peptide-1 Receptor Agonists and Incidence of Dementia Among Older Adults With Type 2 Diabetes: A Target Trial Emulation","title_match":false,"year":2025},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/metformin-cessation-and-dementia-incidence-37878309","doi":"10.1001/jamanetworkopen.2023.39723","journal":"JAMA Network Open","n_participants":41346,"pmid":"37878309","source_url":"https://pubmed.ncbi.nlm.nih.gov/37878309/","study_design":"cohort","title":"Metformin Cessation and Dementia Incidence","title_match":true,"year":2023},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/association-of-metformin-use-with-risk-of-dementia-in-patients-with-39780315","doi":"10.1111/dom.16192","journal":"Diabetes, Obesity and Metabolism","n_participants":3463100,"pmid":"39780315","source_url":"https://pubmed.ncbi.nlm.nih.gov/39780315/","study_design":"meta-analysis","title":"Association of Metformin use with risk of dementia in patients with type 2 diabetes: A systematic review and meta-analysis","title_match":true,"year":2025},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/no-association-between-metformin-initiation-and-incident-dementia-in-37747779","doi":"10.1111/joim.13723","journal":"Journal of Internal Medicine","n_participants":34700,"pmid":"37747779","source_url":"https://pubmed.ncbi.nlm.nih.gov/37747779/","study_design":"cohort","title":"No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetes","title_match":true,"year":2023},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/anti-diabetic-agents-and-the-risks-of-dementia-in-patients-with-type-39716328","doi":"10.1186/s13195-024-01645-y","journal":"Alzheimer's Research & Therapy","n_participants":3462926,"pmid":"39716328","source_url":"https://pubmed.ncbi.nlm.nih.gov/39716328/","study_design":"meta-analysis","title":"Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials","title_match":false,"year":2024},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/metformin-effectively-alleviates-the-symptoms-of-alzheimer-in-rats-by-39585487","doi":"10.1007/s11011-024-01422-8","journal":"Metabolic brain disease","n_participants":null,"pmid":"39585487","source_url":"https://pubmed.ncbi.nlm.nih.gov/39585487/","study_design":null,"title":"Metformin effectively alleviates the symptoms of Alzheimer in rats by lowering amyloid \u03b2 deposition and enhancing the insulin signal","title_match":true,"year":2024},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/cardioprotective-glucose-lowering-agents-and-dementia-risk-a-40193122","doi":"10.1001/jamaneurol.2025.0360","journal":"JAMA neurology","n_participants":164,"pmid":"40193122","source_url":"https://pubmed.ncbi.nlm.nih.gov/40193122/","study_design":"meta-analysis","title":"Cardioprotective Glucose-Lowering Agents and Dementia Risk: A Systematic Review and Meta-Analysis","title_match":false,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/protocol-for-a-randomized-phase-ii-iii-double-blind-placebo-40434891","doi":"10.1097/wad.0000000000000677","journal":"Alzheimer disease and associated disorders","n_participants":326,"pmid":"40434891","source_url":"https://pubmed.ncbi.nlm.nih.gov/40434891/","study_design":null,"title":"Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment: Metformin in Alzheimer Dementia Prevention (MAP)","title_match":true,"year":2025},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/metformin-use-associated-with-reduced-risk-of-dementia-in-patients-30149446","doi":"10.3233/jad-180263","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"30149446","source_url":"https://pubmed.ncbi.nlm.nih.gov/30149446/","study_design":"meta-analysis","title":"Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis","title_match":true,"year":2018},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/metformin-vs-sulfonylurea-use-and-risk-of-dementia-in-us-veterans-28954880","doi":"10.1212/wnl.0000000000004586","journal":"Neurology","n_participants":null,"pmid":"28954880","source_url":"https://pubmed.ncbi.nlm.nih.gov/28954880/","study_design":"cohort study","title":"Metformin vs sulfonylurea use and risk of dementia in US veterans aged \u226565 years with diabetes","title_match":true,"year":2017},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/exercise-and-metformin-counteract-altered-mitochondrial-function-in-31534057","doi":"10.1172/jci.insight.130681","journal":"JCI insight","n_participants":null,"pmid":"31534057","source_url":"https://pubmed.ncbi.nlm.nih.gov/31534057/","study_design":null,"title":"Exercise and metformin counteract altered mitochondrial function in the insulin-resistant brain","title_match":true,"year":2019},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/metformin-other-antidiabetic-drugs-and-risk-of-alzheimer-s-disease-a-22458300","doi":"10.1111/j.1532-5415.2012.03916.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"22458300","source_url":"https://pubmed.ncbi.nlm.nih.gov/22458300/","study_design":"case-control study","title":"Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study","title_match":true,"year":2012},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/effects-of-the-insulin-sensitizer-metformin-in-alzheimer-disease-28538088","doi":"10.1097/wad.0000000000000202","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"28538088","source_url":"https://pubmed.ncbi.nlm.nih.gov/28538088/","study_design":null,"title":"Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study","title_match":true,"year":2017},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/incidence-of-dementia-is-increased-in-type-2-diabetes-and-reduced-by-21297276","doi":"10.3233/jad-2011-101524","journal":"Journal of Alzheimer's disease : JAD","n_participants":127209,"pmid":"21297276","source_url":"https://pubmed.ncbi.nlm.nih.gov/21297276/","study_design":null,"title":"Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin","title_match":true,"year":2011},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/long-term-metformin-usage-and-cognitive-function-among-older-adults-24577463","doi":"10.3233/jad-131901","journal":"Journal of Alzheimer's disease : JAD","n_participants":204,"pmid":"24577463","source_url":"https://pubmed.ncbi.nlm.nih.gov/24577463/","study_design":"cross-sectional","title":"Long-term metformin usage and cognitive function among older adults with diabetes","title_match":true,"year":2014},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/association-of-metformin-sulfonylurea-and-insulin-use-with-brain-30768625","doi":"10.1371/journal.pone.0212293","journal":"PloS one","n_participants":3590,"pmid":"30768625","source_url":"https://pubmed.ncbi.nlm.nih.gov/30768625/","study_design":null,"title":"Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: Pooled analysis from 5 cohorts","title_match":true,"year":2019},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/initiating-second-line-antidiabetic-medication-among-older-adults-35114955","doi":"10.1186/s12877-022-02792-3","journal":"BMC Geriatrics","n_participants":null,"pmid":"35114955","source_url":"https://pubmed.ncbi.nlm.nih.gov/35114955/","study_design":null,"title":"Initiating second-line antidiabetic medication among older adults with type 2 diabetes on Metformin","title_match":true,"year":2022},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/1414-p-characteristics-associated-with-sulfonylureas-and-basal-f7466f98","doi":"10.2337/db20-1414-p","journal":"Diabetes","n_participants":45734,"pmid":null,"source_url":"https://doi.org/10.2337/db20-1414-p","study_design":null,"title":"1414-P: Characteristics Associated with Sulfonylureas and Basal Insulin Use following Metformin in Older Adults","title_match":true,"year":2020},{"alzhub_score":29,"alzhub_url":"https://alzhub.org/study/comprehensive-review-on-alzheimer-disease-causes-risk-factors-837ee353","doi":"10.5281/zenodo.18509182","journal":"Zenodo (CERN European Organization for Nuclear Research)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.5281/zenodo.18509182","study_design":null,"title":"Comprehensive Review on Alzheimer Disease: Causes, Risk Factors, Pathology, Mechanisms","title_match":false,"year":2026},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/comprehensive-review-on-alzheimer-disease-causes-risk-factors-54d0f1d7","doi":"10.5281/zenodo.18509183","journal":"Zenodo (CERN European Organization for Nuclear Research)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.5281/zenodo.18509183","study_design":null,"title":"Comprehensive Review on Alzheimer Disease: Causes, Risk Factors, Pathology, Mechanisms","title_match":false,"year":2026},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/the-exposome-and-pancreatic-cancer-lifestyle-and-environmental-risk-40368260","doi":"10.1016/j.semcancer.2025.05.004","journal":"Seminars in Cancer Biology","n_participants":null,"pmid":"40368260","source_url":"https://pubmed.ncbi.nlm.nih.gov/40368260/","study_design":null,"title":"The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC","title_match":false,"year":2025},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/associations-of-semaglutide-with-alzheimer-s-disease-related-40552638","doi":"10.1177/13872877251351329","journal":"Journal of Alzheimer s Disease","n_participants":null,"pmid":"40552638","source_url":"https://pubmed.ncbi.nlm.nih.gov/40552638/","study_design":null,"title":"Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study","title_match":false,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/evaluating-glp-1-receptor-agonists-versus-metformin-as-first-line-40695613","doi":"10.1136/bmjdrc-2025-004902","journal":"BMJ Open Diabetes Research & Care","n_participants":null,"pmid":"40695613","source_url":"https://pubmed.ncbi.nlm.nih.gov/40695613/","study_design":"cohort study","title":"Evaluating GLP-1 receptor agonists versus metformin as first-line therapy for reducing dementia risk in type 2 diabetes","title_match":true,"year":2025},{"alzhub_score":28,"alzhub_url":"https://alzhub.org/study/diabetes-and-dementia-current-data-ea341fb6","doi":"10.22141/2224-0721.21.2.2025.1521","journal":"INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.22141/2224-0721.21.2.2025.1521","study_design":null,"title":"Diabetes and dementia: current data","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/mechanisms-underlying-cognitive-impairment-and-management-strategies-41169480","doi":"10.3389/fendo.2025.1655768","journal":"Frontiers in Endocrinology","n_participants":null,"pmid":"41169480","source_url":"https://pubmed.ncbi.nlm.nih.gov/41169480/","study_design":null,"title":"Mechanisms underlying cognitive impairment and management strategies in type 2 diabetes","title_match":false,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/antidiabetic-medications-and-risk-of-cognitive-disorders-in-type-2-42636218","doi":"10.1371/journal.pone.0356138","journal":"PLoS ONE","n_participants":1528885,"pmid":"42636218","source_url":"https://pubmed.ncbi.nlm.nih.gov/42636218/","study_design":"cohort study","title":"Antidiabetic medications and risk of cognitive disorders in type 2 diabetes: A retrospective cohort study","title_match":false,"year":2026},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/unravelling-shared-pathways-linking-metabolic-syndrome-mild-cognitive-40137124","doi":"10.3390/metabo15030159","journal":"Metabolites","n_participants":null,"pmid":"40137124","source_url":"https://pubmed.ncbi.nlm.nih.gov/40137124/","study_design":null,"title":"Unravelling Shared Pathways Linking Metabolic Syndrome, Mild Cognitive Impairment, Dementia, and Sarcopenia","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/metformin-protects-against-insulin-resistance-related-dementia-risk-40494433","doi":"10.1016/j.lfs.2025.123803","journal":"Life sciences","n_participants":null,"pmid":"40494433","source_url":"https://pubmed.ncbi.nlm.nih.gov/40494433/","study_design":null,"title":"Metformin protects against insulin resistance-related dementia risk involving restored microglial homeostasis","title_match":true,"year":2025},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/the-role-of-antidiabetic-drugs-in-the-treatment-of-alzheimer-s-37968954","doi":"10.14341/probl13183","journal":"Problemy endokrinologii","n_participants":null,"pmid":"37968954","source_url":"https://pubmed.ncbi.nlm.nih.gov/37968954/","study_design":"meta-analysis","title":"[The role of antidiabetic drugs in the treatment of Alzheimer's disease: systematic review]","title_match":false,"year":2023},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/metformin-promotes-tau-aggregation-and-exacerbates-abnormal-behavior-26858121","doi":"10.1186/s13024-016-0082-7","journal":"Molecular neurodegeneration","n_participants":null,"pmid":"26858121","source_url":"https://pubmed.ncbi.nlm.nih.gov/26858121/","study_design":null,"title":"Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy","title_match":true,"year":2016},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/accelerated-bio-cognitive-aging-in-down-syndrome-state-of-the-art-and-30768754","doi":"10.1111/acel.12903","journal":"Aging cell","n_participants":null,"pmid":"30768754","source_url":"https://pubmed.ncbi.nlm.nih.gov/30768754/","study_design":null,"title":"Accelerated bio-cognitive aging in Down syndrome: State of the art and possible deceleration strategies","title_match":false,"year":2019},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/a-multimodal-precision-prevention-approach-combining-lifestyle-38297399","doi":"10.1186/s13195-023-01355-x","journal":"Alzheimer's research & therapy","n_participants":600,"pmid":"38297399","source_url":"https://pubmed.ncbi.nlm.nih.gov/38297399/","study_design":null,"title":"A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol","title_match":true,"year":2024},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/diabetes-and-aging-from-treatment-goals-to-pharmacologic-therapy-30833929","doi":"10.3389/fendo.2019.00045","journal":"Frontiers in endocrinology","n_participants":null,"pmid":"30833929","source_url":"https://pubmed.ncbi.nlm.nih.gov/30833929/","study_design":null,"title":"Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy","title_match":false,"year":2019},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/metformin-use-is-associated-with-slowed-cognitive-decline-and-reduced-32967921","doi":"10.2337/dc20-0892","journal":"Diabetes care","n_participants":1037,"pmid":"32967921","source_url":"https://pubmed.ncbi.nlm.nih.gov/32967921/","study_design":null,"title":"Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study","title_match":true,"year":2020},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/link-between-type-2-diabetes-and-alzheimer-s-disease-from-25792818","doi":"10.2147/cia.s74042","journal":"Clinical interventions in aging","n_participants":null,"pmid":"25792818","source_url":"https://pubmed.ncbi.nlm.nih.gov/25792818/","study_design":null,"title":"Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment","title_match":false,"year":2015},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/antidiabetic-medication-and-risk-of-dementia-in-patients-with-type-2-31437816","doi":"10.1530/eje-19-0259","journal":"European journal of endocrinology","n_participants":250,"pmid":"31437816","source_url":"https://pubmed.ncbi.nlm.nih.gov/31437816/","study_design":"case-control study","title":"Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case-control study","title_match":false,"year":2019},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/diabetes-drugs-in-the-fight-against-alzheimer-s-disease-31330313","doi":"10.1016/j.arr.2019.100936","journal":"Ageing research reviews","n_participants":null,"pmid":"31330313","source_url":"https://pubmed.ncbi.nlm.nih.gov/31330313/","study_design":null,"title":"Diabetes drugs in the fight against Alzheimer's disease","title_match":false,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/diabetes-drugs-and-neurological-disorders-new-views-and-therapeutic-24622756","doi":"10.1016/s2213-8587(13)70125-6","journal":"The lancet. Diabetes & endocrinology","n_participants":null,"pmid":"24622756","source_url":"https://pubmed.ncbi.nlm.nih.gov/24622756/","study_design":null,"title":"Diabetes drugs and neurological disorders: new views and therapeutic possibilities","title_match":false,"year":2014},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/impact-of-antidiabetic-agents-on-dementia-risk-a-bayesian-network-32446679","doi":"10.1016/j.metabol.2020.154265","journal":"Metabolism: clinical and experimental","n_participants":530355,"pmid":"32446679","source_url":"https://pubmed.ncbi.nlm.nih.gov/32446679/","study_design":"meta-analysis","title":"Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis","title_match":false,"year":2020},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/comparative-efficacy-and-acceptability-of-antidiabetic-agents-for-29790638","doi":"10.1111/dom.13373","journal":"Diabetes, obesity & metabolism","n_participants":4855,"pmid":"29790638","source_url":"https://pubmed.ncbi.nlm.nih.gov/29790638/","study_design":"meta-analysis","title":"Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis","title_match":false,"year":2018},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/liraglutide-improves-memory-in-obese-patients-with-prediabetes-or-31965072","doi":"10.1038/s41366-020-0535-5","journal":"International journal of obesity (2005)","n_participants":20,"pmid":"31965072","source_url":"https://pubmed.ncbi.nlm.nih.gov/31965072/","study_design":null,"title":"Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study","title_match":false,"year":2020},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/emerging-links-between-type-2-diabetes-and-alzheimer-s-disease-26069723","doi":"10.4239/wjd.v6.i5.744","journal":"World journal of diabetes","n_participants":null,"pmid":"26069723","source_url":"https://pubmed.ncbi.nlm.nih.gov/26069723/","study_design":"longitudinal study","title":"Emerging links between type 2 diabetes and Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/antidiabetic-drugs-for-the-risk-of-alzheimer-disease-in-patients-with-32162525","doi":"10.1177/1533317519899546","journal":"American journal of Alzheimer's disease and other dementias","n_participants":85,"pmid":"32162525","source_url":"https://pubmed.ncbi.nlm.nih.gov/32162525/","study_design":null,"title":"Antidiabetic Drugs for the Risk of Alzheimer Disease in Patients With Type 2 DM Using FAERS","title_match":false,"year":2020},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/role-of-insulin-receptor-substance-1-modulating-pi3k-akt-insulin-33927970","doi":"10.1007/s13205-021-02738-3","journal":"3 Biotech","n_participants":null,"pmid":"33927970","source_url":"https://pubmed.ncbi.nlm.nih.gov/33927970/","study_design":null,"title":"Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/diabetes-antidiabetic-medications-and-risk-of-dementia-a-systematic-37869901","doi":"10.1111/dom.15331","journal":"Diabetes, obesity & metabolism","n_participants":100,"pmid":"37869901","source_url":"https://pubmed.ncbi.nlm.nih.gov/37869901/","study_design":"meta-analysis","title":"Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta-analysis","title_match":false,"year":2024},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/biguanide-metformin-acts-on-tau-phosphorylation-via-mtor-protein-21098287","doi":"10.1073/pnas.0912793107","journal":"Proceedings of the National Academy of Sciences of the United States of America","n_participants":null,"pmid":"21098287","source_url":"https://pubmed.ncbi.nlm.nih.gov/21098287/","study_design":null,"title":"Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling","title_match":true,"year":2010},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/increased-risk-of-cognitive-impairment-in-patients-with-diabetes-is-24009301","doi":"10.2337/dc13-0229","journal":"Diabetes care","n_participants":480,"pmid":"24009301","source_url":"https://pubmed.ncbi.nlm.nih.gov/24009301/","study_design":null,"title":"Increased risk of cognitive impairment in patients with diabetes is associated with metformin","title_match":true,"year":2013},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/metformin-treatment-prevents-amyloid-plaque-deposition-and-memory-29253574","doi":"10.1016/j.bbi.2017.12.009","journal":"Brain, behavior, and immunity","n_participants":null,"pmid":"29253574","source_url":"https://pubmed.ncbi.nlm.nih.gov/29253574/","study_design":null,"title":"Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice","title_match":true,"year":2018},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/antidiabetic-drug-metformin-glucophager-increases-biogenesis-of-19237574","doi":"10.1073/pnas.0807991106","journal":"Proceedings of the National Academy of Sciences of the United States of America","n_participants":null,"pmid":"19237574","source_url":"https://pubmed.ncbi.nlm.nih.gov/19237574/","study_design":null,"title":"Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription","title_match":true,"year":2009},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/peripheral-insulin-sensitizer-drug-metformin-ameliorates-neuronal-21277873","doi":"10.1016/j.neuropharm.2011.01.033","journal":"Neuropharmacology","n_participants":null,"pmid":"21277873","source_url":"https://pubmed.ncbi.nlm.nih.gov/21277873/","study_design":null,"title":"Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes","title_match":true,"year":2011},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/metformin-in-amnestic-mild-cognitive-impairment-results-of-a-pilot-26890736","doi":"10.3233/jad-150493","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"26890736","source_url":"https://pubmed.ncbi.nlm.nih.gov/26890736/","study_design":null,"title":"Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial","title_match":true,"year":2016},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/metformin-attenuates-alzheimer-s-disease-like-neuropathology-in-obese-22425595","doi":"10.1016/j.pbb.2012.03.002","journal":"Pharmacology, biochemistry, and behavior","n_participants":null,"pmid":"22425595","source_url":"https://pubmed.ncbi.nlm.nih.gov/22425595/","study_design":null,"title":"Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice","title_match":true,"year":2012},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/metformin-a-future-therapy-for-neurodegenerative-diseases-theme-drug-28589443","doi":"10.1007/s11095-017-2199-y","journal":"Pharmaceutical research","n_participants":null,"pmid":"28589443","source_url":"https://pubmed.ncbi.nlm.nih.gov/28589443/","study_design":null,"title":"Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla","title_match":true,"year":2017},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/metformin-a-review-of-potential-mechanism-and-therapeutic-utility-37397787","doi":"10.2147/dddt.s409373","journal":"Drug design, development and therapy","n_participants":null,"pmid":"37397787","source_url":"https://pubmed.ncbi.nlm.nih.gov/37397787/","study_design":null,"title":"Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes","title_match":true,"year":2023},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/cognitive-impairment-and-vitamin-b12-a-review-22221769","doi":"10.1017/s1041610211002511","journal":"International psychogeriatrics","n_participants":null,"pmid":"22221769","source_url":"https://pubmed.ncbi.nlm.nih.gov/22221769/","study_design":null,"title":"Cognitive impairment and vitamin B12: a review","title_match":false,"year":2012},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/the-dialogue-between-neuroinflammation-and-adult-neurogenesis-36383328","doi":"10.1007/s12035-022-03102-z","journal":"Molecular neurobiology","n_participants":null,"pmid":"36383328","source_url":"https://pubmed.ncbi.nlm.nih.gov/36383328/","study_design":null,"title":"The Dialogue Between Neuroinflammation and Adult Neurogenesis: Mechanisms Involved and Alterations in Neurological Diseases","title_match":false,"year":2023},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/endophenotype-based-in-silico-network-medicine-discovery-combined-35572351","doi":"10.1038/s43587-021-00138-z","journal":"Nature aging","n_participants":null,"pmid":"35572351","source_url":"https://pubmed.ncbi.nlm.nih.gov/35572351/","study_design":"case-control study","title":"Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/metformin-activates-chaperone-mediated-autophagy-and-improves-disease-34291435","doi":"10.1007/s13238-021-00858-3","journal":"Protein & cell","n_participants":null,"pmid":"34291435","source_url":"https://pubmed.ncbi.nlm.nih.gov/34291435/","study_design":null,"title":"Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model","title_match":true,"year":2021},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/ampk-sirt1-pgc-1-signaling-pathway-molecular-mechanisms-and-targeted-41268687","doi":"10.1111/cns.70657","journal":"CNS neuroscience & therapeutics","n_participants":null,"pmid":"41268687","source_url":"https://pubmed.ncbi.nlm.nih.gov/41268687/","study_design":null,"title":"AMPK/SIRT1/PGC-1\u03b1 Signaling Pathway: Molecular Mechanisms and Targeted Strategies From Energy Homeostasis Regulation to Disease Therapy","title_match":false,"year":2025},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/effects-of-metformin-exposure-on-neurodegenerative-diseases-in-28583443","doi":"10.1016/j.pnpbp.2017.06.002","journal":"Progress in neuro-psychopharmacology & biological psychiatry","n_participants":4651,"pmid":"28583443","source_url":"https://pubmed.ncbi.nlm.nih.gov/28583443/","study_design":"cohort study","title":"Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus","title_match":true,"year":2017},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/causal-inference-in-medical-records-and-complementary-systems-36496454","doi":"10.1038/s41467-022-35157-w","journal":"Nature communications","n_participants":null,"pmid":"36496454","source_url":"https://pubmed.ncbi.nlm.nih.gov/36496454/","study_design":null,"title":"Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia","title_match":true,"year":2022},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/deintensification-of-diabetes-medications-among-veterans-at-the-end-32065387","doi":"10.1111/jgs.16360","journal":"Journal of the American Geriatrics Society","n_participants":3056,"pmid":"32065387","source_url":"https://pubmed.ncbi.nlm.nih.gov/32065387/","study_design":"cohort study","title":"Deintensification of Diabetes Medications among Veterans at the End of Life in VA Nursing Homes","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/a-review-of-recent-advances-in-the-management-of-alzheimer-s-disease-38756263","doi":"10.7759/cureus.58416","journal":"Cureus","n_participants":null,"pmid":"38756263","source_url":"https://pubmed.ncbi.nlm.nih.gov/38756263/","study_design":null,"title":"A Review of Recent Advances in the Management of Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/semaglutide-double-edged-sword-with-risks-and-benefits-39902055","doi":"10.26502/aimr.0189","journal":"Archives of internal medicine research","n_participants":null,"pmid":"39902055","source_url":"https://pubmed.ncbi.nlm.nih.gov/39902055/","study_design":null,"title":"Semaglutide: Double-edged Sword with Risks and Benefits","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/diabetes-risk-factor-and-translational-therapeutic-implications-for-35128745","doi":"10.1111/ejn.15619","journal":"The European journal of neuroscience","n_participants":null,"pmid":"35128745","source_url":"https://pubmed.ncbi.nlm.nih.gov/35128745/","study_design":null,"title":"Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/crosstalk-between-alzheimer-s-disease-and-diabetes-a-focus-on-anti-37335453","doi":"10.1007/s11011-023-01225-3","journal":"Metabolic brain disease","n_participants":null,"pmid":"37335453","source_url":"https://pubmed.ncbi.nlm.nih.gov/37335453/","study_design":null,"title":"Crosstalk between Alzheimer's disease and diabetes: a focus on anti-diabetic drugs","title_match":false,"year":2023},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/metformin-induced-changes-in-the-gut-microbiome-and-plasma-metabolome-38871078","doi":"10.1016/j.metabol.2024.155941","journal":"Metabolism: clinical and experimental","n_participants":172,"pmid":"38871078","source_url":"https://pubmed.ncbi.nlm.nih.gov/38871078/","study_design":null,"title":"Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men","title_match":true,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/metformin-macrophage-dysfunction-and-atherosclerosis-34163481","doi":"10.3389/fimmu.2021.682853","journal":"Frontiers in immunology","n_participants":null,"pmid":"34163481","source_url":"https://pubmed.ncbi.nlm.nih.gov/34163481/","study_design":null,"title":"Metformin, Macrophage Dysfunction and Atherosclerosis","title_match":true,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/antiarrhythmic-effects-of-metformin-38840768","doi":"10.1016/j.hroo.2024.04.003","journal":"Heart rhythm O2","n_participants":null,"pmid":"38840768","source_url":"https://pubmed.ncbi.nlm.nih.gov/38840768/","study_design":null,"title":"Antiarrhythmic effects of metformin","title_match":true,"year":2024},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/drug-repurposing-in-oncology-a-systematic-review-of-randomized-37296934","doi":"10.3390/cancers15112972","journal":"Cancers","n_participants":null,"pmid":"37296934","source_url":"https://pubmed.ncbi.nlm.nih.gov/37296934/","study_design":"systematic review","title":"Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/metformin-in-alzheimer-s-disease-an-overview-of-potential-mechanisms-35134385","doi":"10.1016/j.bcp.2022.114945","journal":"Biochemical pharmacology","n_participants":null,"pmid":"35134385","source_url":"https://pubmed.ncbi.nlm.nih.gov/35134385/","study_design":null,"title":"Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings","title_match":true,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/metformin-and-alzheimer-s-disease-dementia-and-cognitive-impairment-a-28800055","doi":"10.11124/jbisrir-2017-003380","journal":"JBI database of systematic reviews and implementation reports","n_participants":null,"pmid":"28800055","source_url":"https://pubmed.ncbi.nlm.nih.gov/28800055/","study_design":null,"title":"Metformin and Alzheimer's disease, dementia and cognitive impairment: a systematic review protocol","title_match":true,"year":2017},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/metformin-age-related-cognitive-decline-and-brain-pathology-37931533","doi":"10.1016/j.neurobiolaging.2023.10.005","journal":"Neurobiology of aging","n_participants":3029,"pmid":"37931533","source_url":"https://pubmed.ncbi.nlm.nih.gov/37931533/","study_design":null,"title":"Metformin, age-related cognitive decline, and brain pathology","title_match":true,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/metformin-ameliorates-mitochondrial-damage-induced-by-c9orf72-poly-gr-38229533","doi":"10.1002/jcb.30526","journal":"Journal of cellular biochemistry","n_participants":null,"pmid":"38229533","source_url":"https://pubmed.ncbi.nlm.nih.gov/38229533/","study_design":null,"title":"Metformin ameliorates mitochondrial damage induced by C9orf72 poly(GR) via upregulating AKT phosphorylation","title_match":true,"year":2024},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/metformin-use-and-brain-atrophy-in-nondemented-elderly-individuals-35843348","doi":"10.1016/j.exger.2022.111890","journal":"Experimental gerontology","n_participants":157,"pmid":"35843348","source_url":"https://pubmed.ncbi.nlm.nih.gov/35843348/","study_design":null,"title":"Metformin use and brain atrophy in nondemented elderly individuals with diabetes","title_match":true,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/metformin-attenuates-tau-pathology-in-tau-seeded-ps19-mice-36422837","doi":"10.1007/s13311-022-01316-6","journal":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","n_participants":null,"pmid":"36422837","source_url":"https://pubmed.ncbi.nlm.nih.gov/36422837/","study_design":null,"title":"Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice","title_match":true,"year":2023},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/drug-repositioning-for-alzheimer-s-disease-finding-hidden-clues-in-32144994","doi":"10.3233/jad-200049","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"32144994","source_url":"https://pubmed.ncbi.nlm.nih.gov/32144994/","study_design":null,"title":"Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs","title_match":false,"year":2020},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/metformin-and-dementia-risk-a-systematic-review-with-respect-to-time-36186728","doi":"10.3233/adr-220002","journal":"Journal of Alzheimer's disease reports","n_participants":null,"pmid":"36186728","source_url":"https://pubmed.ncbi.nlm.nih.gov/36186728/","study_design":"systematic review","title":"Metformin and Dementia Risk: A Systematic Review with Respect to Time Related Biases","title_match":true,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/autophagy-and-tau-protein-34299093","doi":"10.3390/ijms22147475","journal":"International journal of molecular sciences","n_participants":null,"pmid":"34299093","source_url":"https://pubmed.ncbi.nlm.nih.gov/34299093/","study_design":null,"title":"Autophagy and Tau Protein","title_match":false,"year":2021},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/pseudo-dementia-caused-by-metformin-induced-vitamin-b12-deficiency-41564203","doi":"10.24869/psyd.2025.370","journal":"Psychiatria Danubina","n_participants":null,"pmid":"41564203","source_url":"https://pubmed.ncbi.nlm.nih.gov/41564203/","study_design":null,"title":"Pseudo-dementia caused by metformin-induced vitamin B12 deficiency","title_match":true,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/reconsidering-repurposing-long-term-metformin-treatment-impairs-38238285","doi":"10.1038/s41398-024-02755-9","journal":"Translational psychiatry","n_participants":null,"pmid":"38238285","source_url":"https://pubmed.ncbi.nlm.nih.gov/38238285/","study_design":null,"title":"Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer's model mice","title_match":true,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/metformin-new-applications-for-an-old-drug-36474458","doi":"10.1515/jbcpp-2022-0252","journal":"Journal of basic and clinical physiology and pharmacology","n_participants":null,"pmid":"36474458","source_url":"https://pubmed.ncbi.nlm.nih.gov/36474458/","study_design":null,"title":"Metformin: new applications for an old drug","title_match":true,"year":2023},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/approach-toward-diabetes-treatment-in-the-elderly-32377065","doi":"10.14744/semb.2019.00868","journal":"Sisli Etfal Hastanesi tip bulteni","n_participants":null,"pmid":"32377065","source_url":"https://pubmed.ncbi.nlm.nih.gov/32377065/","study_design":null,"title":"Approach Toward Diabetes Treatment in the Elderly","title_match":false,"year":2019},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/pretreatment-with-metformin-prevents-microcystin-lr-induced-tau-34432352","doi":"10.1002/tox.23354","journal":"Environmental toxicology","n_participants":null,"pmid":"34432352","source_url":"https://pubmed.ncbi.nlm.nih.gov/34432352/","study_design":null,"title":"Pretreatment with metformin prevents microcystin-LR-induced tau hyperphosphorylation via mTOR-dependent PP2A and GSK-3\u03b2 activation","title_match":true,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/deciphering-the-roles-of-metformin-in-alzheimer-s-disease-a-snapshot-35153733","doi":"10.3389/fphar.2021.728315","journal":"Frontiers in pharmacology","n_participants":null,"pmid":"35153733","source_url":"https://pubmed.ncbi.nlm.nih.gov/35153733/","study_design":null,"title":"Deciphering the Roles of Metformin in Alzheimer's Disease: A Snapshot","title_match":true,"year":2021},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/metformin-and-trimetazidine-ameliorate-diabetes-induced-cognitive-32000097","doi":"10.1016/j.yebeh.2019.106893","journal":"Epilepsy & behavior : E&B","n_participants":null,"pmid":"32000097","source_url":"https://pubmed.ncbi.nlm.nih.gov/32000097/","study_design":null,"title":"Metformin and trimetazidine ameliorate diabetes-induced cognitive impediment in status epileptic rats","title_match":true,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/repurposing-metformin-for-the-treatment-of-atrial-fibrillation-38919471","doi":"10.2147/vhrm.s391808","journal":"Vascular health and risk management","n_participants":null,"pmid":"38919471","source_url":"https://pubmed.ncbi.nlm.nih.gov/38919471/","study_design":null,"title":"Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights","title_match":true,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/metformin-in-aging-and-aging-related-diseases-clinical-applications-35401820","doi":"10.7150/thno.71360","journal":"Theranostics","n_participants":null,"pmid":"35401820","source_url":"https://pubmed.ncbi.nlm.nih.gov/35401820/","study_design":null,"title":"Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms","title_match":true,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/metformin-mitigates-trimethyltin-induced-cognition-impairment-and-39441380","doi":"10.1007/s10571-024-01502-4","journal":"Cellular and molecular neurobiology","n_participants":null,"pmid":"39441380","source_url":"https://pubmed.ncbi.nlm.nih.gov/39441380/","study_design":null,"title":"Metformin Mitigates Trimethyltin-Induced Cognition Impairment and Hippocampal Neurodegeneration","title_match":true,"year":2024},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/metformin-mitigates-dementia-risk-among-individuals-with-type-2-38725077","doi":"10.1186/s40842-024-00168-7","journal":"Clinical diabetes and endocrinology","n_participants":null,"pmid":"38725077","source_url":"https://pubmed.ncbi.nlm.nih.gov/38725077/","study_design":"longitudinal study","title":"Metformin mitigates dementia risk among individuals with type 2 diabetes","title_match":true,"year":2024},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/metformin-in-elderly-type-2-diabetes-mellitus-dose-dependent-dementia-37878862","doi":"10.1093/brain/awad366","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"37878862","source_url":"https://pubmed.ncbi.nlm.nih.gov/37878862/","study_design":null,"title":"Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction","title_match":true,"year":2024},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/metformin-and-its-sulfenamide-prodrugs-inhibit-human-cholinesterase-28770024","doi":"10.1155/2017/7303096","journal":"Oxidative medicine and cellular longevity","n_participants":null,"pmid":"28770024","source_url":"https://pubmed.ncbi.nlm.nih.gov/28770024/","study_design":null,"title":"Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase Activity","title_match":true,"year":2017},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/role-of-metformin-in-various-pathologies-state-of-the-art-32967584","doi":"10.4155/tde-2020-0102","journal":"Therapeutic delivery","n_participants":null,"pmid":"32967584","source_url":"https://pubmed.ncbi.nlm.nih.gov/32967584/","study_design":null,"title":"Role of metformin in various pathologies: state-of-the-art microcapsules for improving its pharmacokinetics","title_match":true,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/inhibition-of-microtubule-affinity-regulating-kinase-4-by-metformin-35889524","doi":"10.3390/molecules27144652","journal":"Molecules (Basel, Switzerland)","n_participants":null,"pmid":"35889524","source_url":"https://pubmed.ncbi.nlm.nih.gov/35889524/","study_design":null,"title":"Inhibition of Microtubule Affinity Regulating Kinase 4 by Metformin: Exploring the Neuroprotective Potential of Antidiabetic Drug through Spectroscopic and Computational Approaches","title_match":true,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/foresee-novel-targets-for-alzheimer-s-disease-by-investigating-35733313","doi":"10.2174/1871527321666220622162622","journal":"CNS & neurological disorders drug targets","n_participants":null,"pmid":"35733313","source_url":"https://pubmed.ncbi.nlm.nih.gov/35733313/","study_design":null,"title":"Foresee Novel Targets for Alzheimer's Disease by Investigating Repurposed Drugs","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/mechanistic-insight-into-the-role-of-metformin-in-alzheimer-s-disease-34999113","doi":"10.1016/j.lfs.2021.120299","journal":"Life sciences","n_participants":null,"pmid":"34999113","source_url":"https://pubmed.ncbi.nlm.nih.gov/34999113/","study_design":null,"title":"Mechanistic insight into the role of metformin in Alzheimer's disease","title_match":true,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/could-metformin-be-therapeutically-useful-in-huntington-s-disease-31751298","doi":"10.1515/revneuro-2019-0072","journal":"Reviews in the neurosciences","n_participants":null,"pmid":"31751298","source_url":"https://pubmed.ncbi.nlm.nih.gov/31751298/","study_design":null,"title":"Could metformin be therapeutically useful in Huntington's disease?","title_match":true,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/pharmacological-approaches-using-diabetic-drugs-repurposed-for-38255204","doi":"10.3390/biomedicines12010099","journal":"Biomedicines","n_participants":null,"pmid":"38255204","source_url":"https://pubmed.ncbi.nlm.nih.gov/38255204/","study_design":null,"title":"Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/metformin-facilitates-amyloid-generation-by-and-secretases-via-26967226","doi":"10.3233/jad-151200","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"26967226","source_url":"https://pubmed.ncbi.nlm.nih.gov/26967226/","study_design":null,"title":"Metformin Facilitates Amyloid-\u03b2 Generation by \u03b2- and \u03b3-Secretases via Autophagy Activation","title_match":true,"year":2016},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/metformin-prevents-p-tau-and-amyloid-plaque-deposition-and-memory-34283253","doi":"10.1007/s00221-021-06176-8","journal":"Experimental brain research","n_participants":null,"pmid":"34283253","source_url":"https://pubmed.ncbi.nlm.nih.gov/34283253/","study_design":null,"title":"Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice","title_match":true,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/long-term-use-of-metformin-and-alzheimer-s-disease-beneficial-or-36849855","doi":"10.1007/s10787-023-01163-7","journal":"Inflammopharmacology","n_participants":null,"pmid":"36849855","source_url":"https://pubmed.ncbi.nlm.nih.gov/36849855/","study_design":null,"title":"Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects","title_match":true,"year":2023},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/opposite-causal-effects-of-type-2-diabetes-and-metformin-on-alzheimer-40064559","doi":"10.1016/j.tjpad.2025.100129","journal":"The journal of prevention of Alzheimer's disease","n_participants":455017,"pmid":"40064559","source_url":"https://pubmed.ncbi.nlm.nih.gov/40064559/","study_design":null,"title":"Opposite causal effects of type 2 diabetes and metformin on Alzheimer's disease","title_match":true,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/metformin-preferentially-provides-neuroprotection-following-cardiac-32621957","doi":"10.1016/j.bbadis.2020.165893","journal":"Biochimica et biophysica acta. Molecular basis of disease","n_participants":30,"pmid":"32621957","source_url":"https://pubmed.ncbi.nlm.nih.gov/32621957/","study_design":null,"title":"Metformin preferentially provides neuroprotection following cardiac ischemia/reperfusion in non-diabetic rats","title_match":true,"year":2020},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/huntington-s-disease-drug-development-a-phase-3-pipeline-analysis-38004378","doi":"10.3390/ph16111513","journal":"Pharmaceuticals (Basel, Switzerland)","n_participants":null,"pmid":"38004378","source_url":"https://pubmed.ncbi.nlm.nih.gov/38004378/","study_design":"systematic review","title":"Huntington's Disease Drug Development: A Phase 3 Pipeline Analysis","title_match":false,"year":2023},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/risk-reduction-and-precision-prevention-across-the-alzheimer-s-41145344","doi":"10.1016/j.tjpad.2025.100367","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"41145344","source_url":"https://pubmed.ncbi.nlm.nih.gov/41145344/","study_design":null,"title":"Risk reduction and precision prevention across the Alzheimer's disease continuum: a systematic review of clinical trials combining multidomain lifestyle interventions and pharmacological or nutraceutical approaches","title_match":false,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/linking-metabolic-syndrome-to-neurodegeneration-mechanisms-and-40272771","doi":"10.1007/s12035-025-04947-w","journal":"Molecular neurobiology","n_participants":null,"pmid":"40272771","source_url":"https://pubmed.ncbi.nlm.nih.gov/40272771/","study_design":"longitudinal study","title":"Linking Metabolic Syndrome to Neurodegeneration Mechanisms and Potential Treatments","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/rnf168-dephosphorylation-ameliorates-cognitive-decline-in-a-based-40993809","doi":"10.1186/s40478-025-02115-8","journal":"Acta neuropathologica communications","n_participants":null,"pmid":"40993809","source_url":"https://pubmed.ncbi.nlm.nih.gov/40993809/","study_design":null,"title":"RNF168 dephosphorylation ameliorates cognitive decline in A\u03b2-based mouse models of Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/legacy-neuropsychiatric-benefit-after-semaglutide-is-linked-to-8d55012e","doi":"10.64898/2026.04.16.26351060","journal":"medRxiv","n_participants":63215,"pmid":null,"source_url":"https://doi.org/10.64898/2026.04.16.26351060","study_design":"longitudinal study","title":"Legacy neuropsychiatric benefit after semaglutide is linked to maximum achieved dose and independent of the maximum weight lost","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/effect-of-metformin-on-tau-pathology-and-proteostasis-in-cellular-and-a6042b4b","doi":"10.21203/rs.3.rs-10786020/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10786020/v1","study_design":null,"title":"Effect of Metformin on tau pathology and proteostasis in cellular and a Drosophila model of Tauopathy","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/randomized-metformin-and-cognitive-outcomes-in-the-diabetes-f474ce0b","doi":"10.64898/2026.08.05.26359234","journal":"medRxiv","n_participants":1483,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.05.26359234","study_design":"longitudinal study","title":"Randomized metformin and cognitive outcomes in the Diabetes Prevention Program Outcomes Study","title_match":true,"year":2026},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/pharmacologic-therapy-for-type-2-diabetes-mellitus-af75a470","doi":"10.7326/0003-4819-133-1-200007040-00016","journal":"Annals of Internal Medicine","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.7326/0003-4819-133-1-200007040-00016","study_design":"systematic review","title":"Pharmacologic Therapy for Type 2 Diabetes Mellitus","title_match":false,"year":2000},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/british-association-of-dermatologists-guidelines-for-the-management-23121204","doi":"10.1111/bjd.12072","journal":"British Journal of Dermatology","n_participants":null,"pmid":"23121204","source_url":"https://pubmed.ncbi.nlm.nih.gov/23121204/","study_design":null,"title":"British Association of Dermatologists\u2019 guidelines for the management of bullous pemphigoid 2012","title_match":false,"year":2012},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/pharmacokinetic-drugdrug-interaction-study-of-ranolazine-and-2d3045db","doi":"10.1002/cpdd.174","journal":"Clinical Pharmacology in Drug Development","n_participants":28,"pmid":null,"source_url":"https://doi.org/10.1002/cpdd.174","study_design":"clinical trial","title":"Pharmacokinetic drug\u2013drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus","title_match":true,"year":2015},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/evaluating-the-efficacy-and-mechanism-of-metformin-targets-on-35902387","doi":"10.1007/s00125-022-05743-0","journal":"Diabetologia","n_participants":344182,"pmid":"35902387","source_url":"https://pubmed.ncbi.nlm.nih.gov/35902387/","study_design":null,"title":"Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study","title_match":true,"year":2022}]}